Skip to main content
Log in

Studies on interactions between traditional herbal and western medicines. IV: Lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The possibility of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to extract powder (TJ-12), a widely used traditional Chinese herbal (Kampo) medicine, and carbamazepine (CBZ), an important anti-epileptic drug, was examined in rats. There were no significant differences in the serum protein binding of CBZ and carbamazepine-10, 11-epoxide (CBZ-E), its active metabolite, at two concentrations (1 and 10 Bg/ml) between two groups pretreated orally with the vehicle and TJ-12 suspension (1 g/kg/d, p.o.) for 1 week. One-week repeated pretreatment with TJ-12 (1 g/kg/d) did not influence liver weight, contents of cytochromes P450 and b5 in hepatic microsomes or the formation rate of CBZ-E from CBZ by its microsomes, while pretreatment with phenobarbital (80 mg/kg/d, i.p.) significantly increased these paramenters. Neither a single nor 1-week repeated oral pretreatment with TJ-12 (1 g/kg/d) affected the plasma concentration-time profile and any pharmacokinetic parameter of CBZ or CBZ-E after oral administration of CBZ (50 mg/kg). These results indicated that oral co-administration of TJ-12 with CBZ has no effect of the pharmacokinetics of CBZ or CBZ-E in rats. Concomitant treatment with TJ-12 and CBZ appears to be pharmacokinetically safe in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ohnishi N., Yonekawa Y., Fumihara T., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K. (1999). Studies on interactions between traditional herbal and Western medicines. II. Lack of pharmacokinetic interaction between Sho-seiryu-to and carbamazepine in healthy volunteers. Jpn. J. TDM, 16, 399–404.

    Google Scholar 

  2. Iwai A., Sugiyama Y., Kawakami A., Ueno K. (1991). Effects of Saibokuto on theophylline disposition and laboratory findings. Jpn. J. TDM, 8, 57–64.

    Google Scholar 

  3. Hasegawa T., Yamaki K., Nadai M., Muraoka I., Wang L., Takagi K., Nabeshima T. (1994). Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. Int. J. Clin. Pharmacol. Ther., 32, 57–61.

    CAS  PubMed  Google Scholar 

  4. Hasegawa T., Yamaki K., Muraoka I., Nadai M., Takagi K., Nabeshima T. (1995). Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin. Antimicrob. Agents Chemother., 39, 2135–2137.

    CAS  PubMed  Google Scholar 

  5. Homma M., Oka K., Ikeshima K., Takahashi N., Niitsuma T., Fukuda T., Itoh H. (1995). Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J. Pharm. Pharmacol., 47, 687–692.

    CAS  PubMed  Google Scholar 

  6. Qi J., Toyoshima A., Honda Y., Mineshita S. (1997). Pharmacokinetic study on acetaminophen: interaction with a Chinese medicine. J. Med. Dent. Sci., 44, 31–35.

    CAS  PubMed  Google Scholar 

  7. Uno T., Ohkubo T., Sugawara K., Higashiyama A., Motomura S. (1998). Effects of Shigyaku-san (TJ-35) on pharmacokinetics and pharmacodynamics of nicardipine. Iyakuhin-Sogosayo-Kenkyu, 21, 139–145.

    Google Scholar 

  8. Ohnishi N., Yonekawa Y., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K. (1999). Studies on interactions between traditional herbal and Western medicines. III. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats. Biol. Pharm. Bull., 22, 527–531.

    CAS  PubMed  Google Scholar 

  9. Sasaki K., Suzuki K., Yoshizaki F., Ando T. (1995). Effect of Saiko-karyukotsu-borei-to on the stress-induced increase of serum corticosterone in mice. Biol. Pharm. Bull., 18, 563–565.

    CAS  PubMed  Google Scholar 

  10. Senzaki A., Okubo Y., Matsuura M., Kojima T., Toru M. (1993). Clinical studies on effects of Saiko-ka-ryukotsu-borei-to (TJ-12) for adult patients with symptomatic localization-related epilepsy. Rinsho-Seishin-Igaku, 22, 641–646.

    Google Scholar 

  11. Doumas B.T., Watson W.A., Biggs H.G. (1971). Albumin standards and the measurement of derum albumin with bromcresol green. Clin. Chim. Acta, 31, 87–96.

    Article  CAS  PubMed  Google Scholar 

  12. Omura T., Sato R. (1964). The carbon monooxide-binding pigment of liver microsomes. J. Biol. Pharmacol., 239, 2370–2378.

    CAS  Google Scholar 

  13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951). Protein measurement with folin phenol reagent. J. Biol. Pharmacol., 193, 265–275.

    CAS  Google Scholar 

  14. Daniel W., Janczar L., Danek L., Legrum W., Netter K. (1992): Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol., 345, 598–605.

    Article  CAS  Google Scholar 

  15. Yamaoka K. (1984): Drug disposition analysis by microcomputers. Tokyo: Nankodo, 149–159.

    Google Scholar 

  16. Kimura M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H. (1993): Pharmacokinetic interaction of zonisamide in rats. Effect of zonisamide on other antiepileptics. Biol. Pharm. Bull., 16, 722–725.

    CAS  PubMed  Google Scholar 

  17. Chang S.-L., Levy R.H. (1986): Inhibitory effect of valproic acid on the disposition of carbamazepine and carbamazepine-10,11-epoxide in the rat, Drug Metab. Dispos., 14, 281–286.

    CAS  PubMed  Google Scholar 

  18. Iijima O., Minematsu S., Maemura S., Waterson L. A., Gopinath C., Connick H. (1995): A single oral dose toxicity study and a 13-week repeated dose study with a 4-week recovery period of TSUMURA Saikoka-ryukotsu-borei-to (TJ-12) in rats. Jpn. Pharmacol. Ther., 23 (suppl.), S1739-S1753.

    CAS  Google Scholar 

  19. Kang J.-J., Wang H.-W., Liu T.-Y., Chen Y.-C., Ueng T.-H. (1997): Modulation of cytochrome P-450-dependent monooxygenases, glutathion and glutathione S-transferase in rat liver by geniposide from Gardenia jasminoides. Food Chem. Toxicol., 35, 957–965.

    Article  CAS  PubMed  Google Scholar 

  20. Turner P.V., Renton K.W. (1989): The interaction between carbamazepine and erythromycin. Can. J. Physiol. Pharmacol., 67, 582–586.

    CAS  PubMed  Google Scholar 

  21. Faigle J.W., Feldmann K.F. (1995): 40 Carbamazepine, chemistry and biotransformation. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds) Antiepileptic drugs, 4th edn. New York: Raven Press, 499–513.

    Google Scholar 

  22. Shinoda M., Akita M., Hasegawa M., Nadai M., Hasegawa T., Nabeshima T. (1995): Pharmaceutical evaluation of carbamazepine suppositories in rats. Biol. Pharm. Bull., 18, 1289–1291.

    CAS  PubMed  Google Scholar 

  23. Rowland M., Tozer T.N. (Eds) (1989): Clinical pharmacokinetics concepts and applications, 2nd edn. Philadelphia: Lea & Febiger, 148–176.

    Google Scholar 

  24. Mattson G.F., Mattson R.H., Cramer J.A. (1982): Interaction between valproic acid and carbamazepine: an in vitro study of protein binding. Ther. Drug Monit., 4, 181–184.

    Article  CAS  PubMed  Google Scholar 

  25. Lertratanangkoon K., Horning M.G. (1982): Metabolism of carbamazepine. Drug Metab. Dispos., 10, 1–10.

    CAS  PubMed  Google Scholar 

  26. Ohnishi T., Yoneyama H., Hamamoto T., Ishida T., Takahara J., Ichikawa Y. (1996): Induction of cytochrome P-450-linked monooxygenase system in rat liver microsomes by Xiano-Chaihu-Tang. Am. J. Chin. Med., 14, 143–151.

    Google Scholar 

  27. Tamura M., Nose M., Kojima K., Mizukami H., Ogihara Y. (1998): Scientific Evaluation of Kampo (No. 12) Effect of long term administration of Sho-saiko-to on the induction of drug metabolic enzyme (cytochrome P450). J. Trad. Med., 15, 344–345.

    Google Scholar 

  28. Kerr B.M., Thummel K.E., Wurden C.J., Klein S.M., Kroetz D.L., Gonzalez F.J., Levy R.H. (1994): Human liver carbamazepine metabolism, role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol., 47, 1969–1979.

    Article  CAS  PubMed  Google Scholar 

  29. Wilkinson G.R. (1996): Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans. J. Pharmacokin. Biopharmaceut., 24, 475–490.

    Article  CAS  Google Scholar 

  30. Panesar S.K., Bandiera S.M., Abbott F.S. (1996): Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochrome P450 in the rat. Drug Metab. Dispos., 24, 619–627.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohnishi, N., Nakasako, S., Okada, K. et al. Studies on interactions between traditional herbal and western medicines. IV: Lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats. Eur. J. Drug Metab. Pharmacokinet. 26, 129–135 (2001). https://doi.org/10.1007/BF03190386

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190386

Keywords

Navigation